血管内温度管理与体表降温在心脏骤停复苏后昏迷患者中的系统评价与Meta分析
该系统评价与Meta分析比较血管内温度管理(IVTM)与体表降温方法(SCM)用于诱导低温的效果与安全性。检索PubMed、Embase和Cochrane系统评价数据库(2019年5月27日),纳入12项观察性或随机研究,共1573例接受IVTM和4008例接受SCM的院外心脏骤停复苏后成人患者。IVTM组生存率55.0% vs SCM组51.2%,合并风险差2%(95%CI -1%, 5%);神经功能良好结局IVTM组40.9% vs SCM组29.5%,合并风险差5%(95%CI 2%, 8%)。IVTM组心律失常风险降低6%(95%CI 11%, 2%),过度降温风险降低15%(95%CI 22%, 7%)。作者认为IVTM与改善的神经功能结局相关,可能对急诊和ICU复苏后管理有启示。
要点
- 院外心脏骤停复苏后昏迷成人中,IVTM组神经功能良好结局40.9% vs SCM组29.5%,合并风险差5%(95%CI 2%, 8%)。
- IVTM组生存率55.0% vs SCM组51.2%,合并风险差2%(95%CI -1%, 5%),未达统计学显著。
- IVTM组心律失常风险较SCM降低6%(95%CI 11%, 2%),过度降温风险降低15%(95%CI 22%, 7%)。
- 其他评估的不良事件两组间无显著差异。
- 作者认为IVTM与改善的神经功能结局相关,可能对急诊和ICU心脏骤停复苏后患者管理有启示。
适用人群与场景
- 年龄18岁及以上的院外心脏骤停复苏后接受诱导低温治疗的成人患者。
- 纳入比较IVTM与SCM对生存和/或神经功能结局的观察性或随机研究。
研究设计与关键结果
- 系统评价与Meta分析,纳入12项研究,IVTM组1573例,SCM组4008例。
- 生存率:IVTM组55.0% vs SCM组51.2%,合并风险差2%(95%CI -1%, 5%)。
- 神经功能良好结局:IVTM组40.9% vs SCM组29.5%,合并风险差5%(95%CI 2%, 8%)。
- 心律失常风险:IVTM较SCM降低6%(95%CI 11%, 2%)。
- 过度降温风险:IVTM较SCM降低15%(95%CI 22%, 7%)。
- 其他评估的不良事件两组间无显著差异。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,纳入观察性或随机研究。
- 观察性研究质量采用纽卡斯尔-渥太华质量评估工具评分,随机试验采用Cochrane协作组偏倚风险工具评估。
- 采用随机效应模型计算各结局的风险差,使用标准方法评估统计异质性和发表偏倚。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为IVTM与改善的神经功能结局相关,可能对急诊和ICU心脏骤停复苏后患者管理有启示。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To systematically review the effectiveness and safety of intravascular temperature management (IVTM) vs. surface cooling methods (SCM) for induced hypothermia (IH).
METHODS: Systematic review and meta-analysis. English-language PubMed, Embase and the Cochrane Database of Systematic Reviews were searched on May 27, 2019. The quality of included observational studies was graded using the Newcastle-Ottawa Quality Assessment tool. The quality of included randomized trials was evaluated using the Cochrane Collaboration's risk of bias tool. Random effects modeling was used to calculate risk differences for each outcome. Statistical heterogeneity and publication bias were assessed using standard methods.
ELIGIBILITY: Observational or randomized studies comparing survival and/or neurologic outcomes in adults aged 18 years or greater resuscitated from out-of-hospital cardiac arrest receiving IH via IVTM vs. SCM were eligible for inclusion.
RESULTS: In total, 12 studies met inclusion criteria. These enrolled 1573 patients who received IVTM; and 4008 who received SCM. Survival was 55.0% in the IVTM group and 51.2% in the SCM group [pooled risk difference 2% (95% CI -1%, 5%)]. Good neurological outcome was achieved in 40.9% in the IVTM and 29.5% in the surface group [pooled risk difference 5% (95% CI 2%, 8%)]. There was a 6% (95% CI 11%, 2%) lower risk of arrhythmia with use of IVTM and 15% (95% CI 22%, 7%) decreased risk of overcooling with use of IVTM vs. SCM. There was no significant difference in other evaluated adverse events between groups.
CONCLUSIONS: IVTM was associated with improved neurological outcomes vs. SCM among survivors resuscitated following cardiac arrest. These results may have implications for care of patients in the emergency department and intensive care settings after resuscitation from cardiac arrest.
参考来源
- Bartlett ES, Valenzuela T, Idris A, et al. Systematic review and meta-analysis of intravascular temperature management vs. surface cooling in comatose patients resuscitated from cardiac arrest. Resuscitation. 2019. PMID: 31730898. doi:10.1016/j.resuscitation.2019.10.035
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。